Ignite Creation Date:
2025-12-24 @ 12:56 PM
Ignite Modification Date:
2026-02-10 @ 10:48 PM
Study NCT ID:
NCT01933061
Status:
WITHDRAWN
Last Update Posted:
2014-02-04
First Post:
2013-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma
Sponsor:
Celgene Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
None
Primary Completion Date:
2014-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-28
First Submit QC Date:
None
Study First Post Date:
2013-08-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-03
Last Update Post Date:
2014-02-04
Last Update Post Date Type:
ESTIMATED